Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation.
Guillain-Barre Syndrome After Robotically Assisted Laparoscopic Prostatectomy: First Case Report.
The expanded spectrum of neuromyelitis optica: evidences for a new definition.
2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome.
The radial diffusivity and magnetization transfer pool size ratio are sensitive markers for demyelination in a rat model of type III multiple sclerosis (MS) lesions.
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
Fertility treatment in spinal cord injury and other neurologic disease.
Neurological disorders: Differential methylation in multiple sclerosis.
Iron chelation and multiple sclerosis.
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
Management of fatigue in persons with multiple sclerosis.
Exclusive use of alternative medicine as a positive choice: a qualitative study of treatment assumptions among people with multiple sclerosis in denmark.
Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy? Case report and review of the literature.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
HLA associations in South Asian multiple sclerosis.
Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis.
Inhibition of Interferon regulatory factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Pegylated interferons: a nurses' review of a novel multiple sclerosis therapy.
Validity of Maximal Exercise Testing in Patients With Low to Moderate Multiple Sclerosis.
Multiple sclerosis: Could simvastatin slow down secondary progressive MS?
IL1-β expression in multiple sclerosis.
The multiple sclerosis self-management scale: clinicometric testing.
Risk stratification and mitigation in multiple sclerosis.
Simvastatin: Multiple Sclerosis.

Pages